Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas

被引:40
作者
Pradhan, Manohar
Abeler, Vera M.
Danielsen, Harvard E.
Trope, Claes G.
Risberg, Bjorn Ake [1 ]
机构
[1] Natl Hosp Norway, Radiumhosp Med Ctr, Pathol Clin, N-0310 Oslo, Norway
[2] Natl Hosp Norway, Radiumhosp Med Ctr, Dept Med Informat, N-0310 Oslo, Norway
[3] Natl Hosp Norway, Radiumhosp Med Ctr, Dept Gynecol Oncol, Oslo, Norway
关键词
endometrial carcinoma; ploidy; image cytometry;
D O I
10.1038/modpathol.3800641
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Image cytometric DNA ploidy analysis of endometrial carcinomas was performed to determine whether ploidy status and ploidy-related parameters like DNA index, percentage of cells exceeding 5c and 9c, correlate with histologic subtype. This is a prospective study of 391 patients with stage I endometrial carcinoma which included 331 (85%) endometrioid adenocarcinoma, 22 (6%) serous adenocarcinoma, 7 (2%) clear cell adenocarcinoma, 2 (0.5%) small cell carcinoma, 1 (0.3%) undifferentiated carcinoma, and 28 (7%) unclassifiable adenocarcinoma. Twenty-five percent of endometrioid adenocarcinomas were non-diploid. In contrast, all clear cell adenocarcinomas and 21/22 (95%) of serous adenocarcinomas were non-diploid. Hyperdiploidy (25 cases) was found only in endometrioid adenocarcinomas. Mean DNA index of the stemline in serous adenocarcinoma (1.72) and clear cell adenocarcinoma (1.81) was higher than in endometrioid adenocarcinoma (1.1). The difference in ploidy-related parameters between endometrioid adenocarcinoma and serous adenocarcinoma was highly significant (P < 0.001). In addition, Grade 3 endometrioid adenocarcinoma showed significant difference in all ploidy-related parameters compared with grade 1 and grade 2 tumors (P < 0.001). Our results show that DNA ploidy-related parameters may be valuable in subtyping histologically difficult cases of endometrial carcinomas.
引用
收藏
页码:1227 / 1235
页数:9
相关论文
共 28 条
  • [11] Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer
    Kristensen, GB
    Kildal, W
    Abeler, VM
    Kaern, J
    Vergote, I
    Tropé, CG
    Danielsen, HE
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (10) : 1494 - 1500
  • [12] Prognostic significance of DNA ploidy in endometrial cancer
    Larson, DM
    Berg, R
    Shaw, G
    Krawisz, BR
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 74 (03) : 356 - 360
  • [13] Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification
    Lax, SF
    [J]. VIRCHOWS ARCHIV, 2004, 444 (03) : 213 - 223
  • [14] 5-YEAR SURVIVAL RATE IN ENDOMETRIAL CARCINOMA STAGES-I-II - INFLUENCE OF DEGREE OF TUMOR DIFFERENTIATION, AGE, MYOMETRIAL INVASION AND DNA CONTENT
    LINDAHL, B
    RANSTAM, J
    WILLEN, R
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (07): : 621 - 625
  • [15] LINDAHL B, 1987, ANTICANCER RES, V7, P791
  • [16] Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma
    Lundgren, C
    Auer, G
    Frankendal, B
    Moberger, B
    Nilsson, B
    Nordström, B
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (01) : 110 - 118
  • [17] Mangili G, 2002, EUR J GYNAECOL ONCOL, V23, P216
  • [18] Molecular and histopathologic predictors of distant failure in endometrial cancer
    Mariani, A
    Sebo, TJ
    Webb, MJ
    Riehle, D
    Katzmann, JA
    Keeney, GL
    Roche, PC
    Lesnick, TG
    Podratz, KC
    [J]. CANCER DETECTION AND PREVENTION, 2003, 27 (06): : 434 - 441
  • [19] Genomic aberrations in carcinomas of the uterine corpus
    Micci, F
    Teixeira, MR
    Haugom, L
    Kristensen, G
    Abeler, VM
    Heim, S
    [J]. GENES CHROMOSOMES & CANCER, 2004, 40 (03) : 229 - 246
  • [20] NEWBURY R, 1990, OBSTET GYNECOL, V76, P251